Drawing upon a selection of key studies and clinical trials, we aim to provide an in-depth assessment of the current state of knowledge surrounding PD-1/PDL-1 inhibition as an exciting breakthrough in cancer therapy. The gene discussed is CD274; the disease is cancer.